4th Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$2,270,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Science/Technology SCI

- Issues related to data privacy

LobbyistCovered position, as disclosed
LEIF BRIERLEY —
ROBERTO SADA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Civil Rights/Civil Liberties CIV

- HR 5, "Equality Act", regarding all provisions - S 264, "Dream Act of 2021", regarding all provisions - HR 4, "The John Lewis Voting Rights Advancement Act", issues relating to voting rights

LobbyistCovered position, as disclosed
LARRY CAMM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5 (117th), H.R. 4 (117th)

Bankruptcy BNK

- HR 4777/S 2497, "Nondebtor Release Prohibition Act of 2021", regarding all provisions - HR 2096/S 2472, "Stop Shielding Assets from Corporate Known Liability by Eliminating Non-Debtor Releases Act", regarding all provisions - Issues related to corporate Chapter 11 bankruptcy filings and divisive mergers

LobbyistCovered position, as disclosed
RILEY SWINEHART —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4777 (117th), H.R. 2096 (117th)

Health Issues HCR

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, "To allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan.", regarding all provisions - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - HR 3173/S 3018 - "Improving Seniors Timely Access to Care Act of 2021", regarding all provisions - S 3799 - "PREVENT Pandemics Act", regarding all provisions - HR 3932/S 2076 - "PASTEUR Act of 2021", regarding all provisions - HR 5376 - "Inflation Reduction Act", regarding provisions on drug pricing and provisions related to revenue - HR 7559 - Prescription Information Modernization Act of 2022, regarding all provisions - HR 2617 - "Consolidated Appropriations Act, 2023", regarding provisions related to pharmaceuticals, medical devices, mental health, and tax - Issues related to Dengue - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LEIF BRIERLEY —
LARRY CAMM —
DARREL C JODREY —
DAVID KAVANAUGH —
DEANA MCRAE —
AMY PELLEGRINO —
ABIGAIL PINKELE —
ROBERTO SADA —
EMELY SANCHEZ New Intern, HHS OIG: Spring 2016, Intern, CDC CSTLTS: Fall 2017 and Summer 2020, Intern, Rep. Donna Shalala Fall 2019, Intern Senate HELP Committee: Fall 2020
MEGHAN DRENAN STONE —
WENDY SUSSMAN —
RILEY SWINEHART —
TIMOTHY SWOPE New —
COLLEEN VIVALDI New —
KELLY WATERS —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1978 (117th), H.R. 3990 (117th), H.R. 7559 (117th), H.R. 3173 (117th), H.R. 8299 (117th), H.R. 7667 (117th), H.R. 3353 (117th), H.R. 3 (117th), H.R. 5376 (117th), H.R. 6007 (117th), H.R. 5030 (117th), H.Res. 446 (117th), H.R. 1667 (117th), H.R. 3932 (117th), H.R. 2617 (117th), H.R. 5801 (117th)

Budget/Appropriations BUD

- HR 1319, "The American Rescue Plan Act of 2021", regarding all provisions - Issues related to NIH Appropriations (LHHS) - Issues related to HIV/AIDS Ryan White Appropriations (LHHS) and End the Epidemic - Issues related to funding for USAID Appropriations (SFOPS) - Issues pertaining to funding for programs that aim to improve maternal health - Issues pertaining to cross cutting health system strengthening - Issues related to FDA Appropriations - Issues related to contact lenses (FSGG)

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LEIF BRIERLEY —
DARREL C JODREY —
DEANA MCRAE —
ABIGAIL PINKELE —
MEGHAN DRENAN STONE —
KELLY WATERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1319 (117th)

Consumer Issues/Safety/Products CSP

- HR 2116, "Creating a Respectful and Open World for Natural Hair (CROWN ACT)", regarding all provisions - S 936, "INFORM Consumers Act", regarding all provisions - HR 3429/S 1843, "SHOP SAFE Act", regarding all provisions - S 3416, "Protecting Patients from Counterfeit Medical Devices Act", regarding the expansion of the enforcement authority of the FDA with respect to counterfeit devices - HR 6207/S 3357, "Humane Cosmetics Act", regarding all provisions - Issues related to ingredient safety - Issues related to animal testing and consumer products - Issues related to counterfeit consumer products - Issues related to brand protection - Issues related to e-Commerce

LobbyistCovered position, as disclosed
LEIF BRIERLEY —
DARREL C JODREY —
ROBERTO SADA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2116 (117th), H.R. 3429 (117th), H.R. 6207 (117th)

Environment/Superfund ENV

- HR 4800/S 2546, "Reef Safe Act", regarding all provisions - Issues related to environmental sustainability - Issues related to recycling and plastics - Issues related to coral reefs - Issues related to clean energy - Issues related to carbon tax

LobbyistCovered position, as disclosed
DARREL C JODREY —
DEANA MCRAE —
ROBERTO SADA —
RILEY SWINEHART —
KELLY WATERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4800 (117th)

Taxation/Internal Revenue Code TAX

- HR 5214, "To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements.", regarding expenditures from HSAs, FSAs, and health reimbursement arrangements for dietary supplements - Issues related to Health Spending Accounts & Flexible Spending Accounts - Issues related to corporate tax provisions of reconciliation bill - U.S. Treasury policy and negotiating positions related to tax at the Organisation for Economic Co-operation and Development ("OECD") - Issues related to US Treasury implementation of new corporate alternative minimum tax - Issues related to WTO TRIPS agreement

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
DARREL C JODREY —
DAVID KAVANAUGH —
ABIGAIL PINKELE —
WENDY SUSSMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5214 (117th)

Trade (domestic/foreign) TRD

- HR 2884/S 1435, Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act, regarding all provisions - Issues related to mandatory supply chain requirements, including under "Buy America" - Issues related to waiver of WTO TRIPS related to COVID response

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —
TIMOTHY SWOPE New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2884 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.